ライフサイエンスコーパス: supraclavicular

1 para-aortic 5.88 (95% CI, 3.80 to 9.09), and supraclavicular 30.27 (95% CI 16.56 to 55.34).

2 Twenty-two (40%) of 55 patients had supraclavicular abnormalities detected at CT and/or US.

3 In 18 (82%) of the 22 patients, supraclavicular abnormalities were recognizable at CT.

4 by our institution as LABC with ipsilateral supraclavicular adenopathy without evidence of distant d

5 We also found NAMPT expression in supraclavicular adipose tissue (where human BAT is local

6 rtantly, this signature is enriched in human supraclavicular adipose tissue, confirming that these ce

7 ues (SUVmean) were determined bilaterally in supraclavicular and gluteal fat depots.

8 trunks, and cords could be identified in the supraclavicular and infraclavicular regions.

9 dal irradiation (including internal mammary, supraclavicular, and axillary lymph nodes) (nodal-irradi

10 mptoms (without a combined transaxillary and supraclavicular approach).

11 We previously named this activity uptake in supraclavicular area fat ("USA-Fat").

12 were noted: pattern A (uptake localizing to supraclavicular area fat [USA-fat], i.e., without corres

13 In adult humans, BAT mainly exists in supraclavicular areas and its prevalence is associated w

14 Attenuation of supraclavicular arteries and veins was measured with art

15 d to both the internal mammary nodes and the supraclavicular-axillary apical nodes in addition to the

16 olving the chest wall and/or the ipsilateral supraclavicular/axillary lymph nodes.

17 Our results suggest that increased supraclavicular BAT activity is inversely associated wit

18 the relationship between (18)F-FDG uptake in supraclavicular BAT in relation to arterial inflammation

19 was used to retrospectively identify active supraclavicular BAT or supraclavicular quiescent adipose

20 omplex for brown fat determination, leads to supraclavicular BAT paucity or dysfunction, thus renderi

21 However, the developmental origin of supraclavicular BAT remains unknown.

22 SFF was significantly lower (P < 0.0001) in supraclavicular BAT than gluteal WAT in all pediatric su

23 roups: with and without metabolically active supraclavicular BAT.

24 dardized uptake value [SUV] > 2) in cervical-supraclavicular BAT.

25 eage cells when investigating human relevant supraclavicular BAT.

26 Supraclavicular block functionally can be considered an

27 following a single-injection interscalene or supraclavicular block.

28 ly suspected of having recurrent axillary or supraclavicular breast cancer.

29 ic cell marking in mice, we demonstrate that supraclavicular brown adipocytes do not develop from the

30 he pharyngeal mesoderm marks the majority of supraclavicular brown adipocytes.

31 s result in improved analgesia compared with supraclavicular catheters and multiple injections of loc

32 arterial blood volume (V(A)) within cervical-supraclavicular fat (sBAT).

33 Physiologic (18)F-FDG uptake in areas of supraclavicular fat in humans ("USA-Fat") has recently b

34 T showed increased retention in cervical and supraclavicular fat that displayed multilocular lipid dr

35 rom white adipose tissue in the cervical and supraclavicular fat.

36 = .002), and 2-field radiotherapy (without a supraclavicular field) (OR, 0.80; 95% CI, 0.67-0.97; P =

37 The supraclavicular hotspot identified on IRT closely corres

38 Supraclavicular, infraclavicular, and axillary brachial

39 east, regional nodes (axillary, subpectoral, supraclavicular, internal mammary), and extranodal regio

40 ng, chest wall, pelvis, and the subpectoral, supraclavicular, internal mammary, mediastinal, and abdo

41 of high FDG uptake in the left calf, a left supraclavicular lesion and also detected concurrent kera

42 espread osseous metastatic disease and right supraclavicular lymph node enlargement ( Fig 1 ).

43 para-aortic lymph nodes in 21 (21%), and in supraclavicular lymph node in eight (8%).

44 an occult renal clear-cell carcinoma from a supraclavicular lymph node metastasis by analysis of G-b

45 identify and guide needle biopsy of enlarged supraclavicular lymph nodes (> or =0.5 cm short axis).

46 e followed by US-guided sampling of enlarged supraclavicular lymph nodes is a simple and safe method

47 o the infraclavicular, internal mammary, and supraclavicular lymph nodes.

48 The effect of internal mammary and medial supraclavicular lymph-node irradiation (regional nodal i

49 ography scan revealed bilateral cervical and supraclavicular lymphadenopathy (6 x 5 cm with a standar

50 ore referral revealed bilateral cervical and supraclavicular lymphadenopathy (6 x 5 cm).

51 nation was remarkable for bulky cervical and supraclavicular lymphadenopathy.

52 Supraclavicular metastases (31% of patients) were about

53 Patients with ipsilateral supraclavicular metastases but no other evidence of dist

54 Patients with ipsilateral supraclavicular metastases should be included in the sta

55 Supraclavicular metastases were often associated with me

56 Upper-body FDG PET and axillary and supraclavicular MR imaging were performed in 10 patients

57 an indeterminate lesion (n = 1) at US-guided supraclavicular needle sampling.

58 tionship of metastatic tumor to axillary and supraclavicular neurovascular structures.

59 nical T3 tumors or stage III-IV (ipsilateral supraclavicular nodal) disease and for patients with fou

60 Chest wall (68%) and supraclavicular nodes (41%) were the most common sites o

61 s seen in intrathoracic lymph nodes (n = 4), supraclavicular nodes (n = 2), axillary nodes (n = 1), a

62 ts with stage IIIB (with pleural effusion or supraclavicular nodes) to IV NSCLC and performance statu

63 n a patient with metastatic breast cancer to supraclavicular nodes.

64 ut may include contralateral mediastinal and supraclavicular nodes.

65 quate pulmonary function, and no evidence of supraclavicular or contralateral hilar adenopathy.

66 ealed unsuspected N3 nodes (infraclavicular, supraclavicular, or internal mammary) in 32 additional p

67 nodal disease (none, pelvic, para-aortic, or supraclavicular; P < .001).

68 Supraclavicular potential BAT regions were localized wit

69 ively identify active supraclavicular BAT or supraclavicular quiescent adipose tissue (QAT) regions.

70 there were no in-breast recurrences and one supraclavicular recurrence.

71 gnant (18)F-FDG uptake on PET imaging in the supraclavicular region is "muscle uptake" purportedly du

72 The supraclavicular region is a common site for lymph node m

73 So-called muscle uptake in the supraclavicular region may be caused in a significant pr

74 The supraclavicular region was evaluated for the presence of

75 FSF maps of the supraclavicular region were acquired in thermoneutrality

76 measured (18)F-FDG uptake within BAT (in the supraclavicular region) as well as in subcutaneous adipo

77 Receipt of RNI (targeting at least the supraclavicular region).

78 not water) stimulated the temperature of the supraclavicular region, which co-locates to the main reg

79 recorded as also receiving treatment to the supraclavicular region.

80 7 y) showed abnormal (18)F-FDG uptake in the supraclavicular region.

81 orrelate PET findings with CT anatomy in the supraclavicular region.

82 formed on biopsy specimens from the neck and supraclavicular regions in patients undergoing surgery.

83 se temperature and glucose uptake within the supraclavicular regions were compared.

84 she had adenopathy in the left axillary and supraclavicular regions, fullness in the left chest, and

85 lary, infraclavicular, internal mammary, and supraclavicular regions, was documented.

86 therapy (IFRT) to the mediastinum, hila, and supraclavicular regions.

87 = .001), atrial fibrillation (P = .009), and supraclavicular RT (P = .021).

88 udy found no significant association between supraclavicular RT and stroke after controlling for othe

89 ss-sectional study, we compared cold-induced supraclavicular (SCV) BAT activity (percent change in pr

90 Supraclavicular SFF was significantly higher in the cont

91 atic type 1 (little or no T2 mediastinal and supraclavicular signal) to type 4 (T2 signal into both t

92 c patient who first presented with bilateral supraclavicular swelling.

93 Relationships between supraclavicular temperatures (TSCR) from IRT and the met

94 This intense supraclavicular uptake should be recognized and should n